One of the biggest challenges to professionals involved in immunisation delivery in recent years has been the controversy surrounding the safety of the measles, mumps and rubella (MMR) vaccine. This article explores the history of the vaccine, the controversy and its impact on uptake rates. In discussion potential winners and losers are considered with the conclusion being that there are very few winners among the affected healthcare professionals, children, parents, the NHS and UK government .
Afzal MA, Minor PD, Begle J., Bentley MC, Armitage E., Ghoah S., Ferguson A. (1998) Absence of measles-virus genome in inflammatory bowel disease. The Lancet351(9103): 646-7.
2.
Ashraf H. (2001) US expert group rejects link between MMR and autism . The Lancet357(9245): 1341.
3.
Bedford H., Booy R., Dunn D., DiGuiseppi C., Gibb D., Gilbert R., Logan S., Peckham C., Roberts I., Tookey P. (1998). Autism, inflammatory bowel disease and MMR vaccine . The Lancet351(9106): 907.
4.
Beard M. (2001) Consultant who linked MMR jab to autism quits after `political pressure'. See: http://news.independent.co.uk/uk/health_medical/article147068.ece (accessed 25 May 2006).
5.
Black C., Kaye J.A., Jick H. ( 2002). Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. British Medical Journal325: 419-21.
6.
Burgess DC, Burgess MA, Leask J. (2006). The MMR vaccination and autism controversy in United Kingdom 1998-2005: Inevitable community outrage or a failure of risk communication?Vaccine24: 3921-8. Casiday R., Cresswell T., Wilson D., Panter-Black C. (2006). A survey of parental attitudes to the MMR vaccine and trust in medical authorityVaccine24: 177-84.
7.
Chadwick N., Bruce I.J., Schepelman S., Pounder RE, Wakefield AJ (1998). Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by polymerase chain reactionJournal of Medical Virology70: 305-11. Chen W., Landau S., Sham P., Fombonne E. (2004) No evidence for links between autism, MMR and measles virusPsychological Medicine34(3): 543-53.
8.
Deer B. ( 2005) MMR scare doctor faces list of charges See: www.timesonline.co.uk/article/o,,8122-1774388,00.htlm (accessed 4 July 2006).
9.
Demicheli V., Jefferson T., Rivetti A., Price D. (2005). Vaccines for measles, mumps and rubella in childrenThe Cochrane Database of Systematic Reviews4: Article No: CD004407.pub2. DOI: 10.1002/14651858.CD004407.pub2.
10.
Department of Health. (2006) Choice matters: increasing choice improves patients' experiencesHMSO: London.
11.
Farrington CP, Miller E., Taylor B. (2001) MMR and autism: further evidence against a causal association. Vaccine19(27): 3632-5. References (Contd)
12.
Fisher BL (1998) Autism, inflammatory bowel disease and MMR vaccine . The Lancet351(9112): 1357-8.
13.
General Medical Council. (2003) Target payments for preventative health measures See: www.gmcuk.org/guidance/library/targeting_preventative_measures.asp (accessed 12 July 2006).
14.
Health Protection Agency. (2006) Laboratory confirmed cases of measles, mumps and rubella, in England and Wales: January to March 2006Communicable Disease Report Weekly16(25): 7.
15.
Health Protection Agency. (2006a) Measles notifications and deaths in England and Wales: 1940-2004 See: www.hpa.org.uk/infections/topics_az/measles/nots_and_deaths.htm (accessed 3 July 2006).
16.
Hodgson H. (2004) A statement by The Royal Free and University College Medical School and The Royal Free Hampstead NHS TrustThe Lancet363(9411): 824.
17.
Honda H., Shimizu Y., Rutter M. (2005) No effect of MMR with drawal on the incidence of autism: a total population study. Journal of Child Psychology and Psychiatry46(6): 572-9.
18.
Horton R. (1998) Autism, inflammatory bowel disease and MMR vaccine . The Lancet351(9106): 909.
19.
Horton R. (2004) The lessons of MMR. The Lancet 363(9411): 747-9. Horton R. (2004a). A statement by the editors of The LancetThe Lancet363(9411): 820-1.
20.
Jabs. (2006). The UK MMR vaccination briefing note: April 2006 See: www.jabs.org.uk/pages/information.htm (accessed 4 July 2006). Jefferson T., Price D., Demicheli V., Bianco E. (2003). Unintended events following immunization with MMR: a systematic reviewVaccine21: 3954-60.
21.
Kaye J., del Mar Melero-Montes M., Jick H. ( 2001) Mumps, measles and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysisBritish Medical Journal322: 460-3. Lee JW, Melgaard B., Clements CJ, Kane M., Mulholland EK, Olive J-M. (1998). Autism, inflammatory bowel disease and MMR vaccineThe Lancet351(9106): 905.
22.
Legal Services Commission. (2003) Decision to remove funding for MMR litigation upheld on appeal See: www.mmrthefacts.nhs.uk/news/newsitem.php?id=59 (accessed 4 July 2006).
23.
Lewin J., Dhillon AP, Sim R., Mazure G., Pounder RE, Wakefield AJ (1995) Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. Gut36(4): 564-9.
24.
Lindley KJ, Milla PJ (1998) Autism, inflammatory bowel disease and MMR vaccine . The Lancet351(9106): 907.
25.
Lyall S. (2002) Britain tries to quell fear over vaccine for childrenThe New York Times: 11 February.
26.
Madsen KM, Hviid A., Vestergaard M., Schendel D., Wohlfahrt J., Thorsen P., Olsen J., Melbye M. (2002) A population-based study of measles, mumps and rubella vaccination and autism. New England Journal of Medicine347(19): 1477-82.
27.
Mäkelä A., Nuorti J.P., Peltola H. (2002) Neurological disorders after measles-mumps-rubella vaccinationPediatrics110(5): 957-63. Montgomery SM, Morris DL, Pounder RE, Wakefield AJ (1999). Paramyxovirus infections in childhood and subsequent inflammatory bowel diseaseGastroenterology116(4): 796-803.
28.
Miller C. (2004) The MMR debate: probability and relative risk. New Law Journal154(7119): 365.
29.
Murch SH, Anthony A., Casson DH, Malik M., Berelowitz M., Dhillon AP, Thomson MA, Valentine A., Davies SE and Walker-Smith JA (2004) Retraction of an interpretation. The Lancet363(9411): 750.
30.
Nhs. (2006) Immunisation: why our children must be protected See: www.mmrthefacts.nhs.uk/news/newsitem.php?id=109 (accessed 20 July 2006).
31.
O'Dell L., Brownlow C. (2005) Media reports and links between MMR and autism: a discourse analysis. British Journal of Learning Disabilities33: 194-9.
32.
Offit PA, Coffin SE (2003) Communicating science to the public: MMR vaccine and autism. Vaccine22: 1-6.
33.
Passwell JH (1999) MMR vaccination, Crohn's disease and autism: a real or imagined `stomach ache/headache?'Israel Medical Association Journal1: 176-7.
34.
Peltola H., Patja A., Leinikki P., Valle M., Davidkin I., Paunio M. (1998) No evidence for measles, mumps and rubella vaccine associated inflammatory bowel disease or autism in a 14-year prospective study (research letters). The Lancet351(9112): 1327-8.
35.
Poltorak M., Leach M., Fairhead J., Cassell J. (2005) `MMR talk' and vaccination choices: an ethnographic study in Brighton. Social Science and Medicine61: 709-19.
36.
Ramsay S. (2002) UK government tries to control MMR panic. The Lancet359(9306): 590.
37.
Robins J. (2003) `Why have they let us down?'The Independent 23 September 2003: 12. See: http://news.independent.co.uk/uk/legal/article88150.ece (accessed 14 July 2006).
38.
Smeeth L., Cook C., Fombonne E., Heavey L., Rodrigues LC, Smith PG, Hall AJ ( 2004) MMR vaccination and pervasive developmental disorders: a case-control studyThe Lancet364(9438): 963-9.
39.
Smith Gcs, Pell JP ( 2003) Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials . British Medical Journal327: 1459-61. Stroud L. (2005) MMR — public policy in crisis: whose tragedy?Journal of Health Organisation and Management19(3): 252-9.
40.
Takahashi H., Suzumura S., Shriakizawa F., Wada N., Tanaka-Taya K., Arai S., Okabe N., Ichikawa H., Sato T. ( 2003) An epidemiological study on Japanese autism concerning routine childhood immunization historyJapanese Journal of Infectious Diseases56: 114-7.
41.
Taylor B., Miller E., Lingam R., Andrews N., Simmons A., Stowe J. (2002) Measles, mumps and rubella vaccination and bowel problems or development regression in children with autism: population study . British Medical Journal324: 393-6.
42.
Uhlmann V., Martin CM, Sheils O., Pilkington L., Silva I., Killalea A., Murch SB, Walker-Smith J., Thomson M., Wakefield AJ and O'Leary JJ (2002) Potential viral pathogenic mechanism for new variant inflammatory bowel diseaseJournal of Clinical Pathology Molecular Pathology55: 84-90.
43.
Wakefield AJ, Murch SH, Anthony A., Linnell J., Casson DM, Malik M., Berelowitz M., Dillon AP, Thomson MA, Harvey P., Valentine A., Davies SE, Walker-Smith JA (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet351(9103): 637-41.
44.
Wakefield AJ, Anthony A., Schepelmann S., Murch SH, Montgomery SM, Walker-Smith JA (1998) Persistent measles virus infection and immunodeficiency in children with autism, ileo-colonic lymphoid nodular hyperplasia and non-specific colitis. Gut42 (Supplement 1): A86.
45.
Wakefield AJ (2004) A statement by Dr Andrew Wakefield. The Lancet363(9411): 823-4.
46.
Wakefield AJ, Harvey P., Linnell J. (2004) MMR — responding to retraction. The Lancet363: 1327-8.
47.
What Doctor's Don't Tell You (2006) MMR and autism: oh deer. E-News Broadcast: 15 June 2006. See: www.wddty.co.uk (accessed 15 June 2006 ).
48.
Wilson K., Mills E., Ross C., McGowan J., Jadad A. (2003). Association of autistic spectrum disorder and the measles, mumps and rubella vaccine: a systematic review of current epidemiological evidenceArchives of Pediatric and Adolescent Medicine157(7): 628-34. World Health Organization. (2001). Recent concerns regarding MMR vaccine Statement WHO/02: 25 January 2001. See: www.who.int/infpr-2001/en/state2001-02.html (accessed 27 June 2006).
